Literature DB >> 8489162

Early diagnosis of otologic Wegener's granulomatosis using the serologic marker C-ANCA.

J D Macias1, P A Wackym, B F McCabe.   

Abstract

Wegener's granulomatosis is a systemic vasculitis that may involve any organ system. Otologic manifestations are common, and can be the presenting complaint. In the past, diagnosis often necessitated the development of characteristic pulmonary or renal disease. The identification of a new serologic marker, cytoplasmic pattern antineutrophil cytoplasmic autoantibody (C-ANCA), allows for the early diagnosis of Wegener's granulomatosis and gives the patient the best chance for remission with cytotoxic therapy. We report two patients with Wegener's granulomatosis who presented with refractory otitis media, one of whom subsequently developed facial nerve paralysis, in which an early diagnosis was facilitated by the use of the C-ANCA test. Otologic manifestations of Wegener's granulomatosis and the basis of the C-ANCA test are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8489162     DOI: 10.1177/000348949310200503

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  4 in total

1.  Wegener granulomatosis involving the pterygopalatine fossa: an unusual case of trigeminal neuropathy.

Authors:  Kathlyn Marsot-Dupuch; Sebastien Clement De Givry; Michel Ouayoun
Journal:  AJNR Am J Neuroradiol       Date:  2002-02       Impact factor: 3.825

2.  Wegener's granulomatosis presenting as bilateral otalgia with facial palsy: a case report.

Authors:  Jeong Hyun Lee; Kun Woo Kim; Na Hye Myong; Jae Yun Jung
Journal:  Korean J Audiol       Date:  2013-04-16

Review 3.  Clinic manifestations in granulomatosis with polyangiitis.

Authors:  A Greco; C Marinelli; M Fusconi; G F Macri; A Gallo; A De Virgilio; G Zambetti; M de Vincentiis
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-18       Impact factor: 3.219

4.  Pathways to renal biopsy and diagnosis among patients with ANCA small-vessel vasculitis.

Authors:  C J Poulton; P H Nachman; Y Hu; J G McGregor; J C Jennette; R J Falk; S L Hogan
Journal:  Clin Exp Rheumatol       Date:  2013-01-23       Impact factor: 4.473

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.